An area dedicated to enhancing the technical and personal skills present in m-Squared to offer our customers the most suitable tools to increase their business. To increase the value and competitiveness of a company, not only economic skills are needed, but also knowledge of the target and related sectors as well as communication and interpersonal skills. And, more than anything else, we do not neglect these.

We are on the side of companies that want to focus on the development of new products and services or on the renewal of their commercial offers, to increase internal value and to bring value to the outside, in their society and in the country where they live and work.

m-Squared consulting is the operational technical reference point able to guide this change, supporting companies in the various decision-making phases: from the definition of target product profiles and development plans, through the identification of the regulatory and commercial strategy, to the in/out licensing activities.

A great expertise in Pharma and Life Sciences
We support companies active in the development of new pharmaceutical and biotech products (new chemical entities, repurposing, reformulation) or wanting to renew their commercial portfolio with the aim of becoming a partner able to strategically support them in the different decision-making phases of the development cycle:
Definition of the Target Product Profile;
Definition of the development plan;
Identification of the regulatory strategy;
Commercial strategy;
In/out licensing activities.

A) Product development status: identification of therapeutic target. Commercial proposal: strategic product consultancy activities.

  1. Identification of the opportunity;
  2. Project analysis;
  3. Identification of competitors (in development and commercial);
  4. Analysis of intellectual property;
  5. Definition of the Target Product Profile and development plan (preclinical; CMC; clinical);
  6. Identification of technical partners for the development of the project:
    – Preclinical CROs;
    – Supply chain;
    – Technology transfer;
    – Scale up;
    – Clinical validation;
    – Regulatory Advice.
  7. Creation/consolidation of business plans;
  8. Presentation to investors;
  9. Negotiations.

  1. Identification of the opportunity;
  2. Project analysis;
  3. Identification of competitors (in development and commercial);
  4. Analysis of intellectual property;
  5. Definition of the Target Product Profile and development plan (preclinical; CMC; clinical);
  6. Identification of technical partners for the development of the project:
    – Preclinical CROs;
    – Supply chain;
    – Technology transfer;
    – Scale up;
    – Clinical validation;
    – Regulatory Advice.
  7. Creation/consolidation of business plans;
  8. Presentation to investors;
  9. Negotiations.

  1. Identification of the opportunity;
  2. Project profitability analysis;
  3. Definition of the development plan;
  4. Identification of technical partners;
  5. Product and territory regulatory strategy;
  6. Creation/consolidation of business plans;
  7. Business Development activities of the product/dossier (national/international);
  8. Identification of commercial and/or development partners;
  9.  Negotiations.

  1. Identification of the opportunity;
  2. Project profitability analysis (market);
  3. Definition of the development plan (preclinical);
  4. Identification of technical partners (preclinical; CMC);
  5. Product and territory regulatory strategy;
  6. Creation/consolidation of business plans;
  7. Business Development activities of the product/dossier (national/international);
  8. Identification of commercial and/or development partners;
  9. Negotiations.

  1. Analysis of the dossier;
  2. Product and territory regulatory strategy;
  3. Business Development activities of the product/dossier (national/international);
  4. Identification of commercial and/or development partners;
  5. Negotiations.

  1. Business Development activities of the product/dossier (national/international)

  1. Identification of the opportunity;
  2. Project profitability analysis (market);
  3. Definition of the development plan (preclinical);
  4. Identification of technical partners (preclinical; CMC) requires a clinical CRO;
  5. Product and territory regulatory strategy;
  6. Creation/consolidation of business plans;
  7. Business Development activities of the product/dossier (national/international);
  8. Identification of commercial and/or development partners;
  9. Negotiations.

We give life to your ideas

Contact Us